SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001493152-21-003884
Filing Date
2021-02-16
Accepted
2021-02-16 11:06:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 157602
2 ex1.htm EX-1 14232
  Complete submission text file 0001493152-21-003884.txt   173482
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81034 | Film No.: 21634270
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 POST RD WEST 2ND FLOOR WESTPORT CT 06880
Business Address 55 POST RD WEST 2ND FLOOR WESTPORT CT 06880 646-793-9056
Ayrton Capital LLC (Filed by) CIK: 0001698148 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A